Book contents
- Stahl’s Self-Assessment Examination in Psychiatry
- Stahl’s Self-Assessment Examination in Psychiatry
- Copyright page
- Contents
- Introduction/Preface
- CME Information
- 1 Basic Neuroscience
- 2 Psychosis and Schizophrenia and Antipsychotics
- 3 Unipolar Depression and Antidepressants
- 4 Bipolar Disorder and Mood Stabilizers
- 5 Anxiety Disorders and Anxiolytics
- 6 Chronic Pain and its Treatment
- 7 Disorders of Sleep and Wakefulness and Their Treatment
- 8 Attention Deficit Hyperactivity Disorder (ADHD) and its Treatment
- 9 Dementia and Cognitive Function and its Treatment
- 10 Substance Use and Impulsive Compulsive Disorders and their Treatment
- Optional Posttests and CME Certificates
- Index
- References
6 - Chronic Pain and its Treatment
Published online by Cambridge University Press: 19 October 2021
Book contents
- Stahl’s Self-Assessment Examination in Psychiatry
- Stahl’s Self-Assessment Examination in Psychiatry
- Copyright page
- Contents
- Introduction/Preface
- CME Information
- 1 Basic Neuroscience
- 2 Psychosis and Schizophrenia and Antipsychotics
- 3 Unipolar Depression and Antidepressants
- 4 Bipolar Disorder and Mood Stabilizers
- 5 Anxiety Disorders and Anxiolytics
- 6 Chronic Pain and its Treatment
- 7 Disorders of Sleep and Wakefulness and Their Treatment
- 8 Attention Deficit Hyperactivity Disorder (ADHD) and its Treatment
- 9 Dementia and Cognitive Function and its Treatment
- 10 Substance Use and Impulsive Compulsive Disorders and their Treatment
- Optional Posttests and CME Certificates
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Stahl's Self-Assessment Examination in PsychiatryMultiple Choice Questions for Clinicians, pp. 233 - 258Publisher: Cambridge University PressPrint publication year: 2019
References
References
Ballantyne, JC, Shin, NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain 2008;24:469–78.1CrossRefGoogle ScholarPubMed
References
McMahon, S, Koltzenburg, M (eds). Wall and Melzack’s textbook of pain, fifth edition. London: Harcourt Publishers; 2005.1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)2Google Scholar
Stahl, SM. Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press; 2009. (Chapters 3–4)3Google Scholar
References
McMahon, S, Koltzenburg, M (eds). Wall and Melzack’s textbook of pain, fifth edition. London: Harcourt Publishers; 2005.1Google Scholar
Stahl, SM. Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press; 2009. (Chapter 2)2Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)3Google Scholar
References
Bennett, RM, Friend, R, Marcus, D, et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken) 2014;66(9):1364–73.1Google Scholar
Wolfe, F, Clauw, DJ, Fitzcharles, MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62(5):600–10.2Google Scholar
References
Stahl, SM. Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press; 2009. (Chapter 5)1CrossRefGoogle Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)2Google Scholar
References
Dooley, DJ, Taylor, CP, Donevan, S, Feltner, D. Ca2+ channel alpha 2 delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci 2007;28:75–82.1Google Scholar
Stahl, SM. Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press; 2009. (Chapter 5)2Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)3Google Scholar
References
Stahl, SM. Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press; 2009. (Chapter 2)1CrossRefGoogle Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)2Google Scholar
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology: the prescriber’s guide, sixth edition. New York, NY: Cambridge University Press; 2017.2Google Scholar
References
Stahl, SM. Case studies: Stahl’s essential psychopharmacology. New York, NY: Cambridge University Press; 2011.1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)2Google Scholar
References
Scholz, BA, Hammonds, CL, Boomershine, CS. Duloxetine for the management of fibromyalgia syndrome. J Pain Res 2009;2:99–108.1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology: the prescriber’s guide, sixth edition. New York, NY: Cambridge University Press; 2017.2Google Scholar
References
Stahl, SM, Felker, A. Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants. CNS Spectr 2008;13(10):855–70.1Google Scholar
Wimbiscus, M, Kostenko, O, Malone, D. MAO inhibitors: risks, benefits, and lore. Curr Drug Therapy 2010;77(2):859–82.2Google Scholar
Reference
Abrams, DI, Couey, P, Shade, SB, Kelly, ME, Benowitz, NL. Cannabinoid–opioid interaction in chronic pain. Clin Pharmacol Ther 2011;90(6):844–51.1CrossRefGoogle ScholarPubMed
Andreae, MH, Carter, GM, Shaparin, N, et al. Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data. J Pain 2015;16(12):1221–32.2Google Scholar
Beltramo, M. Cannabinoid type 2 receptor as a target for chronic pain. Mini Rev Med Chem 2009;9(1):11–25.3Google Scholar
National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017. doi:https://doi.org/10.17226/24625.4Google Scholar
Walker, JM, Hohmann, AG, Martin, WJ, Strangman, NM, Huang, SM, Tsou, K. The neurobiology of cannabinoid analgesia. Life Sci 1999;65(6–7):665–73.5Google Scholar
Whiting, PF, Wolff, RF, Deshpande, S et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015;313(24): 2456–73.6Google Scholar